Articles

A Focus on the Treatment of Anthracycline Extravasation and Tissue Protection

Anthracycline Extravasation For 40 years, the use of anthracycline anticancer drugs has been a mainstay in the curative and palliative treatment of...

A gastrointestinal stromal tumour presenting incidentally with haemorrhage and perforation associated with a Meckel’s diverticulum: a case report

IntroductionThis is the first reported case of perforation andhaemorrhage of a Meckel’s diverticulum leading to theincidental finding of a...

A Practical Clinical Approach to Adjuvant Therapy in Breast Cancer—An Update

Advances in gene expression and molecular profiling have clarified that breast cancer is not a single disease entity, but a heterogeneous disease...

A Primary Pancreatic Carcinoid Tumor with Unusual Clinical Complaints - A Case Report

In the recent revised classification of neuroendocrine tumors,6 the size of 2cm seems to be a crucial value over which carcinoid tumors start to...

A Synopsis of Cancer-related Anorexia and Weight Loss

The presence of this condition can be emotionally distressing to the patient and family. Although options do exist to stimulate appetite, prevent...

Absence of Annexin I Expression in B-cell Non-Hodgkin s Lymphomas and Cell Lines

Increased expression of intracellular annexin I is seen in bronchial epithelial cells grown in the presence of dexamethasone,9 and secreted annexin I...

Accelerated Partial Breast Irradiation for Early-stage, Low-risk Breast Cancer

The reason that so few women choose BCT is largely due to the inconvenience of attending six to seven weeks of daily radiation treatments (RT). Often...

Adjuvant Radiation Therapy for Locally Advanced Bladder Cancer

Although the majority of worldwide bladder cancer patients presented with disease confined to the superficial layers of the bladder wall,...

Adjuvant Treatment of Breast Cancer in Older Patients

Surgery is the primary treatment of choice in early-stage breast cancer for patients of all ages. Older patients who do not undergo surgical removal...

Advances in Chemotherapy Options for Head and Neck Cancer

Over the past 25 years, systemic chemotherapy has been intensively investigated in the management of squamous cell head and neck cancer. Although...

Advances in Image-guided Radiotherapy - The Future is in Motion

Historical Overview Different approaches toward IGRT have been followed over the years. In the 1990s, the first electronic portal imaging devices...

Advances in Pancreatic Cancer Treatment

For the past 10 years, many cytotoxic and targeted agents have been pitted against or combined with gemcitabine in randomized phase III trials and no...

Advances in Radiation Therapy

The advent of broader access to computed tomography (CT) and computing technology led to the first technological revolution in the 1980s. 3-D...

Advances in the Prognosis and Treatment of Medullary or Anaplastic Thyroid Cancer

While ATC is characterised by an almost fatal outcome, with survival that rarely exceeds one year regardless of the available therapy,1 unselected...

Advances in the Prognosis and Treatment of Medullary or Anaplastic Thyroid Cancer

Thyroid cancer accounts for approximately only 1% of all reported malignancies, but is the most common endocrine malignancy.1 It is of either...

Advances in the Surgical Treatment of Lung Cancer

Position Emission Tomography Positron emission tomography (PET) is one of the most exciting advances in the diagnosis of many cancers, including...

Advances in the Treatment of Castration-resistant Prostate Cancer

Hormonal Therapy Androgen ablation has long been the mainstay of treatment of advanced prostate cancer; however, development of resistance to this...

Advances in the Treatment of Metastatic Melanoma Through Radiotherapy

However, more recently there has been a realisation that melanoma displays a wide variety of radiosensitivity and that in some patients large lesions...

Advances in the Treatment Options for Kidney Cancer— Is There an Optimal Regimen?

In 2008, primary kidney malignancies accounted for a predicted 4% of all cancer diagnoses in the US. There were an estimated 54,390 new diagnoses of...

Advances in Treatment Options for Patients with Pancreatic Cancer

The aim of systemic treatment in any cancer is to cure the disease, prolong survival by three to four months or relieve symptoms more than...

Copyright® 2004 - 2010 Business Briefings, Ltd. All rights reserved.
Touch Oncology is for informational purposes and should not be considered medical advice, diagnosis or treatement recommendations.